EpiBone

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

EpiBone is a biomedical engineering company that is developing technology to create bone tissue from a patient's mesenchymal stem cells in vitro for use in bone grafts.[1][2]

History

[edit | edit source]

EpiBone was founded in 2013 by Nina Tandon and Sarindr “Ik” Bhumiratana in New York City.[3] The company’s technology derives from research in bone and osteochondral tissue engineering at Columbia University.[4][failed verification]

See also

[edit | edit source]

References

[edit | edit source]
  1. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  2. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  3. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  4. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
Stub icon

This article about biomedical engineering is a stub. You can help Wikipedia by expanding it.

Stub icon

This article about a corporation or company specializing in health technology is a stub. You can help Wikipedia by expanding it.

Retrieved from "http://70.231.62.181/index.php?title=EpiBone&oldid=22226277"